Industry

#

Industry leaders and organizations are driving the adoption of New Approach Methodologies (NAMs) through innovative technologies, research, and advocacy. This section highlights companies and institutes advancing human-relevant, animal-free science in drug development and biomedical research.

Aspect Biosystems - 3D Bioprinting Platform

#

Aspect Biosystems has developed bioprinted human tissue models designed to replace animal testing in drug development. These bioprinted therapeutics are designed to replace biological functions in the body, representing a major innovation in Canadian biotechnology. These models provide advanced tissue platforms that enhance the accuracy of preclinical drug testing.
Aspect Biosystems

Cherry Biotech - Organoid Culture Made Easy

#

Cherry Biotech provides life-like preclinical data for derisking drug testing and improving preclinical trials. Their experience and expertise with organoids, AI, and biosensors enable the acceleration and improvement of result analysis.
Cherry Biotech

Emulate Bio - Organ-on-a-Chip Technology

#

Emulate Bio develops organ-on-a-chip technology that recreates human physiology to improve drug development, disease modeling, and predictive toxicology. Their platforms enable human-relevant research and reduce reliance on animal testing.
Emulate Bio

Torch Bio - Advancing Drug Discovery

#

A Michigan-based company whose mission is to revolutionize pharmaceutical development by harnessing cutting-edge technologies, including patient-derived iPSC liver organoids and advanced AI models.
Torch Bio

Canadian Institute for Animal-Free Science

#

Formerly known as Canadian Centre for Alternatives to Animal Methods, CCAAM was Canada’s first dedicated academic center for NAM research, promoting human-relevant, non-animal approaches in science. Established in 2017 at the University of Windsor, the center was instrumental in conducting and disseminating research on advanced alternative methods. Its work has been halted due to the lack of a sustained funding commitment from government. Its principal, Charu Chandrasekera, Ph.D., strives to continue the drive toward the adoption and validation of NAMs within Canada under the new organization, the Canadian Institute for Animal-Free Science.